Publications by authors named "Sharon Hashmueli"

Claim this Profile
T
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies.
Adi Mor, Scott Friedman, Sharon Hashmueli, Amnon Peled, Massimo Pinzani

Drug Saf· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression.
Ilana Mandel, Dana Haves Ziv, Ilana Goldshtein, Tsuri Peretz, Dror Alishekevitz, Sharon Hashmueli

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage.
Michal Segal-Salto, Neta Barashi, Avi Katav, Vicktoria Edelshtein, Arnon Aharon, Sharon Hashmueli

JHEP Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease.
Ari Zimran, Einat Brill-Almon, Raul Chertkoff, Milan Petakov, Francisco Blanco-Favela, Sharon Hashmueli

Blood· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigation.
David Aviezer, Einat Brill-Almon, Yoseph Shaaltiel, Sharon Hashmueli, Daniel Bartfeld

PLoS One· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
Yoseph Shaaltiel, Daniel Bartfeld, Sharon Hashmueli, Gideon Baum, Einat Brill-Almon

Plant Biotechnol J· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A truncated IFN-regulatory factor-8\IFN consensus sequence-binding protein acts as dominant-negative, interferes with endogenous protein-protein interactions and leads to apoptosis of immune cells.
Sharon Hashmueli, Merav Gleit-Kielmanowicz, David Meraro, Aviva Azriel, Doron Melamed

Int Immunol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICSBP/IRF-8 transactivation: a tale of protein-protein interaction.
Ben-Zion Levi, Sharon Hashmueli, Merav Gleit-Kielmanowicz, Aviva Azriel, David Meraro

J Interferon Cytokine Res· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The eukaryote chaperonin CCT is a cold shock protein in Saccharomyces cerevisiae.
Lilach Somer, Oshrit Shmulman, Tali Dror, Sharon Hashmueli, Yechezkel Kashi

Cell Stress Chaperones· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis